Review
Prophylaxis of cytomegalovirus infection after bone marrow transplantation
Affiliations
- PMID: 1319612
Item in Clipboard
Review
Prophylaxis of cytomegalovirus infection after bone marrow transplantation
Semin Oncol.
1992 Jun.
Abstract
Viral infections occur frequently during the reconvalescence phase of allogeneic bone marrow transplantation due to the persistence of severe immunodeficiency. Recent advances in the treatment of cytomegalovirus-associated interstitial pneumonia have resulted in the development of an effective strategy for the prevention of this disease. Cytomegalovirus infection as determined by rapid culture from prospective bronchoalveolar lavage specimens on day +35 has been identified as a formidable risk factor for the development of pneumonia. Preemptive therapy with ganciclovir alone prevents the evolution from infection to pneumonia in this subgroup while protecting most other patients from unnecessary drug exposure.
Similar articles
-
A randomized, controlled trial of prophylactic ganciclovir for cytomegalovirus pulmonary infection in recipients of allogeneic bone marrow transplants; The City of Hope-Stanford-Syntex CMV Study Group.N Engl J Med. 1991 Apr 11;324(15):1005-11. doi: 10.1056/NEJM199104113241501. N Engl J Med. 1991. PMID: 1848679 Clinical Trial.
-
Randomized clinical trial of ganciclovir vs acyclovir for prevention of cytomegalovirus antigenemia after allogeneic transplantation.Bone Marrow Transplant. 2002 Dec;30(12):945-51. doi: 10.1038/sj.bmt.1703770. Bone Marrow Transplant. 2002. PMID: 12476289 Clinical Trial.
-
Treatment and prophylaxis of cytomegalovirus infection after bone marrow transplantation.Recent Results Cancer Res. 1993;132:161-74. doi: 10.1007/978-3-642-84899-5_17. Recent Results Cancer Res. 1993. PMID: 8265858 Review. No abstract available.
-
Cytomegalovirus surveillance and prevention in allogeneic bone marrow transplantation: examination of a preemptive plan of ganciclovir therapy.Am J Hematol. 1996 Feb;51(2):104-11. doi: 10.1002/(SICI)1096-8652(199602)51:2<104::AID-AJH2>3.0.CO;2-1. Am J Hematol. 1996. PMID: 8579049 Clinical Trial.
-
Management of human cytomegalovirus infection and disease after allogeneic bone marrow transplantation.Haematologica. 1999 Jan;84(1):71-9. Haematologica. 1999. PMID: 10091394 Review.